Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenhai Yu

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
Signal Transduction and Targeted Therapy|March 4, 2022
Immunogenicity and protective efficacy of a recombinant protein subunit vaccine and an inactivated vaccine against SARS-CoV-2 variants in non-human primatesQian He, Qunying Mao, Xiaozhong Peng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2019
Correction: A Novel Neutralizing Antibody Specific to the DE Loop of VP1 Can Inhibit EV-D68 Infection in MiceHuiwen Zheng, Jingjing Wang, Bingxiang Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 5, 2018
A Novel Neutralizing Antibody Specific to the DE Loop of VP1 Can Inhibit EV-D68 Infection in MiceHuiwen Zheng, Jingjing Wang, Bingxiang Li, et al.
Advanced Materials (Deerfield Beach, Fla.)|May 25, 2019
Efficient Delivery of Nerve Growth Factors to the Central Nervous System for Neural RegenerationDuo Xu, Di Wu, Meng Qin, et al.
Signal Transduction and Targeted Therapy|March 28, 2025
CHIKV mRNA vaccines encoding conserved structural/envelope proteins confer broad cross-lineage protection against infectionXiaoming Liang, Yanan Zhou, Yun Yang, et al.
Signal Transduction and Targeted Therapy|April 25, 2021
The olfactory route is a potential way for SARS-CoV-2 to invade the central nervous system of rhesus monkeysLi Jiao, Yun Yang, Wenhai Yu, et al.
Signal Transduction and Targeted Therapy|February 26, 2022
Three doses of prototypic SARS-CoV-2 inactivated vaccine induce cross-protection against its variants of concernTianhong Xie, Shuaiyao Lu, Zhanlong He, et al.
Medcomm|August 5, 2025
The Biological Characteristics and Mouse Model of Lassa Virus From the First Imported Case in ChinaYanan Zhou, Junbin Wang, Ranran Cao, et al.
Signal Transduction and Targeted Therapy|November 5, 2024
A protein vaccine of RBD integrated with immune evasion mutation shows broad protection against SARS-CoV-2Ran An, Hao Yang, Cong Tang, et al.
Cell Host & Microbe|March 11, 2017
Generation of a Live Attenuated Influenza Vaccine that Elicits Broad Protection in Mice and FerretsLulan Wang, Su-Yang Liu, Hsiang-Wen Chen, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Signal Transduction and Targeted Therapy|March 4, 2022
Immunogenicity and protective efficacy of a recombinant protein subunit vaccine and an inactivated vaccine against SARS-CoV-2 variants in non-human primatesQian He, Qunying Mao, Xiaozhong Peng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2019
Correction: A Novel Neutralizing Antibody Specific to the DE Loop of VP1 Can Inhibit EV-D68 Infection in MiceHuiwen Zheng, Jingjing Wang, Bingxiang Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 5, 2018
A Novel Neutralizing Antibody Specific to the DE Loop of VP1 Can Inhibit EV-D68 Infection in MiceHuiwen Zheng, Jingjing Wang, Bingxiang Li, et al.
Advanced Materials (Deerfield Beach, Fla.)|May 25, 2019
Efficient Delivery of Nerve Growth Factors to the Central Nervous System for Neural RegenerationDuo Xu, Di Wu, Meng Qin, et al.
Signal Transduction and Targeted Therapy|March 28, 2025
CHIKV mRNA vaccines encoding conserved structural/envelope proteins confer broad cross-lineage protection against infectionXiaoming Liang, Yanan Zhou, Yun Yang, et al.
Signal Transduction and Targeted Therapy|April 25, 2021
The olfactory route is a potential way for SARS-CoV-2 to invade the central nervous system of rhesus monkeysLi Jiao, Yun Yang, Wenhai Yu, et al.
Signal Transduction and Targeted Therapy|February 26, 2022
Three doses of prototypic SARS-CoV-2 inactivated vaccine induce cross-protection against its variants of concernTianhong Xie, Shuaiyao Lu, Zhanlong He, et al.
Medcomm|August 5, 2025
The Biological Characteristics and Mouse Model of Lassa Virus From the First Imported Case in ChinaYanan Zhou, Junbin Wang, Ranran Cao, et al.
Signal Transduction and Targeted Therapy|November 5, 2024
A protein vaccine of RBD integrated with immune evasion mutation shows broad protection against SARS-CoV-2Ran An, Hao Yang, Cong Tang, et al.
Cell Host & Microbe|March 11, 2017
Generation of a Live Attenuated Influenza Vaccine that Elicits Broad Protection in Mice and FerretsLulan Wang, Su-Yang Liu, Hsiang-Wen Chen, et al.
Pageof 10